Highlights Roche Holding AG Berne S.E.

Equities

RO

CH0012032113

Delayed Berne S.E. Other stock markets 17:00:03 17/04/2024 BST			5-day change	1st Jan Change
237.4 ^CHF	-2.51%		-0.47%	-8.62%

06-07	Roche: efficacy of Evrysdi in spinal muscular atrophy	CF
06-07	Roche's Five-year Data Confirms Efficacy, Safety of Evrysdi Drug for Spinal Muscular Atrophy in Children	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Roche: efficacy of Evrysdi in spinal muscular atrophy	06-07	CF
Roche's Five-year Data Confirms Efficacy, Safety of Evrysdi Drug for Spinal Muscular Atrophy in Children	06-07	MT
Novartis, Roche's Genentech Among Companies Facing Italian Competition Watchdog Inquiry Over Eye Drug	06-07	MT
Astra's Enhertu breast cancer trial shows 'unprecedented' results	06-02	RE
Astra's Enhertu delays breast cancer in patients with low HER2 levels	06-02	RE
Swiss Stocks Fall as Rate Jitters Intensify Amid Latest Inflation Data	05-29	MT
Global markets live: BHP, Anglo American, Lenovo, Nvidia, Apple...	05-29
Roche Holding AG Announces U.S. Food and Drug Administration Accepted the New Drug Application and Granted Priority Review to Inavolisib, an Investigational, Oral Therapy, in Combination with Palbociclib (Ibrance®) and Fulvestrant	05-29	CI
Roche renews diagnostic partnership with Hitachi	05-27	CF
Roche and Hitachi High-Tech Extend Their 46-Year Partnership, Paving the Way for Further Breakthroughs in Diagnostic Testing	05-27	CI
UK Watchdog Launches Probe into Roche's LumiraDx Purchase	05-24	MT
Roche, LumiraDx Deal Probed by U.K. Competition Watchdog	05-24	DJ
Roche Gets US FDA Breakthrough Designation For Lipoprotein(a) Test	05-22	MT
Roche Receives FDA Device Designation for Blood Test Measuring Lp(a)	05-22	CI
Europe stock pickers go old-school to ride the next wave in AI	05-22	RE
FDA Grants Breakthrough Therapy Designation to Roche's Inavolisib for Advanced Hormone Receptor-Positive, Hormone-Positive, Hormon Receptor 2-Negative Breast Cancer with A PIK3CA Mutation	05-21	CI
UK Competition Watchdog Considers Probe into Roche's Purchase of LumiraDx Business	05-20	MT
UK'S CMA: INVITES COMMENTS ON ROCHE / LUMIRADX DEAL FROM ANY IN…	05-20	RE
Health Care Up on Rotation to Sector From Rate-Sensitive Groups -- Health Care Roundup	05-17	DJ
Roche: share price stands out, Deutsche Bank in support	05-17	CF

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ROCHE HOLDING : In line quarterly results won’t cut it for Roche

April 24, 2024 at 04:50 pm

Obesity: Roche joins the battle

December 04, 2023 at 03:48 pm